Fny Investment Advisers, LLC Nektar Therapeutics Transaction History

Fny Investment Advisers, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 Apr 09, 2020	SELL	$14.47 - $27.96 $243,096 - $469,728	-16,800 Closed	0 $0
Q4 2019 Jan 10, 2020	BUY	$15.87 - $23.12 $20,631 - $30,056	1,300 Added 8.39%	16,800 $362,000
Q3 2019 Oct 25, 2019	BUY	$16.91 - $36.27 $262,105 - $562,185	15,500 New	15,500 $282,000

128

111M

150K

Ticker NKTR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,404,992
Market Cap $231M
Description
Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...

Get notified when there are updates to the investment portfolio of Fny Investment Advisers, LLC, based on Form 13F filings with the SEC.

Stay updated on Fny Investment Advisers, LLC with notifications on news.